Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.1 USD | -0.75% | -4.90% | -32.10% |
05-24 | HC Wainwright Adjusts Legend Biotech Price Target to $73 From $86, Maintains Buy Rating | MT |
05-24 | Deutsche Bank Starts Legend Biotech With Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.10% | 7.55B | |
+9.69% | 118B | |
+9.84% | 106B | |
-11.39% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.61% | 15.97B | |
+6.56% | 14.03B | |
+16.22% | 11.67B |
- Stock Market
- Equities
- LEGN Stock
- News Legend Biotech Corporation
- Legend Biotech Q1 Net Loss Narrows as Revenue Rises; Shares Rise Pre-Bell